Vytrus Biotech

vytrus.com

Biotech company specialized in the development, production and commercialization of high added value active ingredients from the technology of plant stem cells, for cosmetics and dermocosmetics.

C-Suite On Deck

Responsive image

Feature market insights and perspectives from top C-Level executives, elite technology influencers and thought leaders from your company here. This signature initiative has garnered immense support...

Contact Us

Events

Related News

AMYRIS COLLABORATES WITH INFECTIOUS DISEASE RESEARCH INSTITUTE TO ADVANCE A NOVEL RIBONUCLEIC ACID VACCINE PLATFORM WITH COVID-19 VACCINE

Amyris | October 23, 2020

news image

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced the signing of a Collaboration Agreement and License Agreement with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine. The collaboration will combine IDRI's RNA vacci...

Read More

AZELASTINE, AN ANTIHISTAMINE NASAL SPRAY IDENTIFIED AS A PREVENTIVE OR POST-EXPOSURE ANTI-COVID-19 APPROACH

CEBINA | July 13, 2020

news image

CEBINA GmbH, an Austrian biotech company, announces positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays. One of these drugs, Azelastine an antihistamine currently available as a nasal spray, has been identified as a potential topical preventive or post-exposure anti-COVID-19 approach.CEBINA, in collaboration with Professor Robert Konrat, a renowned structural biologis...

Read More

CELL AND GENE THERAPY

MISSION BIO AND S2 GENOMICS TO PROVIDE TUMOR SAMPLE FOR SINGLE-CELL DNA ANALYSIS

Mission Bio | April 20, 2022

news image

Mission Bio, Inc., a leader in high-throughput single-cell DNA and multi-omics analysis, announced today a co-marketing agreement with S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for single-cell applications, to provide a single streamlined workflow for solid tumor applications from sample prep to analysis. Christine A. Iacobuzio-Donahue, MD, Ph.D., Director of the Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer ...

Read More

MEDICAL

ALGAENERGY AGREEMENTS WITH LABORATOIRE M2 FOR DISTRIBUTION AND PRODUCT DEVELOPMENT

AlgaEnergy | January 14, 2021

news image

AlgaEnergy N.A. Inc., the U.S. subsidiary of Spain-based AlgaEnergy S.A. furthermore, a worldwide pioneer in microalgae biotechnology, has marked worldwide item conveyance and item improvement concurrences with Laboratoire M2 Inc., a Quebec-based biotechnology organization that creates normal and practical disinfectant items, including THYMOX CONTROL® fungicide and bactericide. AlgaEnergy formulates and creates incredible, manageable, microalgae-based yield contributions for t...

Read More
news image

AMYRIS COLLABORATES WITH INFECTIOUS DISEASE RESEARCH INSTITUTE TO ADVANCE A NOVEL RIBONUCLEIC ACID VACCINE PLATFORM WITH COVID-19 VACCINE

Amyris | October 23, 2020

Amyris, Inc. (Nasdaq: AMRS), a leading synthetic biotechnology company in Clean Health and Beauty markets through its consumer brands, and a top supplier of sustainable and natural ingredients, today announced the signing of a Collaboration Agreement and License Agreement with the Infectious Disease Research Institute (IDRI) to advance a novel ribonucleic acid (RNA) vaccine platform, including accelerating the development of a COVID-19 vaccine. The collaboration will combine IDRI's RNA vacci...

Read More
news image

AZELASTINE, AN ANTIHISTAMINE NASAL SPRAY IDENTIFIED AS A PREVENTIVE OR POST-EXPOSURE ANTI-COVID-19 APPROACH

CEBINA | July 13, 2020

CEBINA GmbH, an Austrian biotech company, announces positive results of its COVID-19 drug repurposing project with the identification of commonly used approved drugs with activity against SARS-CoV-2 infection in in vitro assays. One of these drugs, Azelastine an antihistamine currently available as a nasal spray, has been identified as a potential topical preventive or post-exposure anti-COVID-19 approach.CEBINA, in collaboration with Professor Robert Konrat, a renowned structural biologis...

Read More
news image

CELL AND GENE THERAPY

MISSION BIO AND S2 GENOMICS TO PROVIDE TUMOR SAMPLE FOR SINGLE-CELL DNA ANALYSIS

Mission Bio | April 20, 2022

Mission Bio, Inc., a leader in high-throughput single-cell DNA and multi-omics analysis, announced today a co-marketing agreement with S2 Genomics, Inc., a leading developer of laboratory automation solutions for processing solid tissues for single-cell applications, to provide a single streamlined workflow for solid tumor applications from sample prep to analysis. Christine A. Iacobuzio-Donahue, MD, Ph.D., Director of the Center for Pancreatic Cancer Research at Memorial Sloan Kettering Cancer ...

Read More
news image

MEDICAL

ALGAENERGY AGREEMENTS WITH LABORATOIRE M2 FOR DISTRIBUTION AND PRODUCT DEVELOPMENT

AlgaEnergy | January 14, 2021

AlgaEnergy N.A. Inc., the U.S. subsidiary of Spain-based AlgaEnergy S.A. furthermore, a worldwide pioneer in microalgae biotechnology, has marked worldwide item conveyance and item improvement concurrences with Laboratoire M2 Inc., a Quebec-based biotechnology organization that creates normal and practical disinfectant items, including THYMOX CONTROL® fungicide and bactericide. AlgaEnergy formulates and creates incredible, manageable, microalgae-based yield contributions for t...

Read More